QuantumScape enters the next quarter at a pivotal moment. The company moves from lab‑scale development to real‑world validation after shipping its B1 sample cells, a key milestone noted in recent reports.

The Volatility Index (VIX) has now fallen below 14, which has positive ramifications over the intermediate-term. VIX in the low teens is among the most bullish, low-risk setups that we have seen over time.